Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Three doses of BNT162b2 (observational)
Two doses of Coronavac and one dose BNT162b2 (observational)
Locations
1
Chile
Red de Salud UC Christus
Santiago, Chile
Start Date
October 27, 2021
Primary Completion Date
March 1, 2022
Completion Date
June 1, 2022
Last Updated
February 2, 2022
NCT06631287
NCT05141058
NCT06679140
NCT06160128
NCT07300839
NCT05566483
Lead Sponsor
Pontificia Universidad Catolica de Chile
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions